Press release
Disulfiram Market worth $521.63 million by 2030, growing at a CAGR of 4.81% - Exclusive Report by 360iResearch
Disulfiram Market | 360iResearch
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/disulfiram
Disulfiram, known as Antabuse, is utilized primarily for treating chronic alcoholism by causing severe physical reactions when alcohol is ingested, thus discouraging consumption. Its chemical makeup, C10H20N2S4, categorizes it as a thiuram derivative, typically available in oral tablets. This medication fills a critical therapeutic gap, being the only one that creates an aversive reaction to alcohol intake. It is administered in clinical settings and included in comprehensive treatment programs featuring counseling and behavioral therapies. With usage in hospitals, addiction treatment centers, clinics, rehabilitation facilities, military, and prisons, disulfiram addresses a broad scope of public health concerns caused by alcohol abuse. Key growth factors in the market include rising incidences of Alcohol Use Disorders (AUDs), government and NGO initiatives, and increased public awareness of alcohol abuse's harmful effects. Opportunities exist for geographic expansion in emerging markets, integrating telemedicine for enhanced treatment adherence, and developing formulations such as extended-release tablets to address compliance issues. However, challenges such as adverse effects, social stigma, competing therapies, regulatory hurdles, and patient reluctance due to severe reactions persist. Innovations in drug delivery systems, combination therapies, and genetic research offer potential advancements. Research areas focusing on behavioral impacts, quality of life assessments, and comparative efficacy studies with other AUD medications could improve the effectiveness of disulfiram. The market is characterized by moderate competition and indirect competition from alternative AUD treatments, with dynamics influenced by regulatory frameworks, healthcare policies, and social attitudes. Strategic partnerships with rehabilitation centers and NGOs, continuous education and training for healthcare providers, and robust patient support programs are recommended to enhance disulfiram's market position and foster growth.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/disulfiram
Market Segmentation & Coverage:
This research report categorizes the Disulfiram Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Indication, market is studied across Alcoholism Treatment and Co-occurring Disorders.
Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Key Company Profiles:
The report delves into recent significant developments in the Disulfiram Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alkem Laboratories Ltd., Allergan plc, Aspen Pharmacare Holdings Limited, Aurobindo Pharma Limited, Bausch Health Companies Inc., Bayer AG, Cipla Inc., Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Lupin Pharmaceuticals, Inc., Merck KGaA, Mylan N.V., Novartis AG, Odyssey pharmaceuticals inc, Par pharmaceutical inc, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Watson laboratories Inc., and Zydus Lifesciences Limited.
Introducing 360iResearch AI: Revolutionizing Market Intelligence with AI-Powered Insights for the Disulfiram Market
We proudly unveil Research AI, a cutting-edge AI product designed to transform how businesses interact with the Disulfiram Market. Research AI stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, Research AI is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it's a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Disulfiram Market. Embrace the future of market analysis with Research AI, where informed decisions lead to remarkable growth.
Ask Question to Research AI @ https://www.360iresearch.com/library/intelligence/disulfiram
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Disulfiram Market, by Indication
7. Disulfiram Market, by Distribution Channel
8. Americas Disulfiram Market
9. Asia-Pacific Disulfiram Market
10. Europe, Middle East & Africa Disulfiram Market
11. Competitive Landscape
12. Competitive Portfolio
Read More @ https://www.360iresearch.com/library/intelligence/disulfiram
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Disulfiram Market worth $521.63 million by 2030, growing at a CAGR of 4.81% - Exclusive Report by 360iResearch here
News-ID: 3601269 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Disulfiram
Optic Atrophy Management Market Size Projected To Reach $11.64 Billion By 2034 W …
The Optic Atrophy Management Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Optic Atrophy Management Market?
In the past few years, the market size for optic atrophy management has seen robust growth. It's expected to increase from $8.3 billion…
Prominent Optic Atrophy Management Market Trend for 2025: Innovative Drug Soluti …
How Are the key drivers contributing to the expansion of the optic atrophy management market?
The optic atrophy management market expects substantial growth due to the projected rise in glaucoma cases. Glaucoma is a group of eyestrain conditions caused by an increase in pressure within the eye, leading to potential optic nerve damage and potential vision loss or blindness if not treated. The expected rise in glaucoma cases acts as the…
Anticipated Surge In Glaucoma Cases Drives Optic Atrophy Management Market Growt …
What Are the Projected Growth and Market Size Trends for the Optic Atrophy Management Market?
The optic atrophy management market has experienced substantial growth in recent years. It will rise from $8.3 billion in 2024 to $8.97 billion in 2025, at a compound annual growth rate (CAGR) of 8.1%. The growth can be attributed to the rapid expansion of consumer electronics, the telecommunications industry, medical device manufacturing, increased demand in the…
Substance Abuse Treatment Market rising at an impressive 12.40% CAGR between 201 …
A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their…
Substance Abuse Treatment Market rising at an impressive 12.40% CAGR between 201 …
A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their…
Substance Abuse Treatment Market rising at an impressive 12.40% CAGR between 201 …
A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their astute marketing…
